Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the field of regenerative medicine. The Company's business is focused on both the development and commercialization of embryonic stem (ES)... more

Curis, Inc. is a drug discovery and development company committed to leveraging signaling pathway drug technologies in seeking to create new medicines, primarily for cancer. The Company’s product development approach consists of generating small molecules to target one or more of the... more

CuraGen Corporation (CuraGen) is a biopharmaceutical development company engaged in developing therapeutics for the treatment of cancer. The Company is focused on advancing its cancer treatments, belinostat and CR011-vcMMAE, through clinical development and toward commercialization. In... more

QLT Inc. is a global biopharmaceutical company with two commercial products, Visudyne and Eligard, which were derived from its two technology platforms, photodynamic therapy and Atrigel. The Company's research and development efforts are focused on pharmaceutical products in the fields of... more

Maxygen, Inc. (Maxygen), incorporated on May 7, 1996, is a biotechnology company involved in the discovery and development of next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions. As of December 31, 2007, the Company had three of its... more

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, co- promotes INTEGRILIN® (eptifibatide) Injection, a market-leading cardiovascular product, and has a robust clinical development pipeline of product... more

Entelos, Inc. is engaged in pharmaceutical research and development consulting activities to accelerate drug discovery, development and commercialization. In August 2007, the Company acquired Iconix Biosciences, Inc. During the year ended December 31, 2007, the Company completed the... more

TheraVitae is an international biotechnology company at the forefront of regenerative medicine with a mission to make the benefits of adult stem cell therapy accessible and affordable to the millions of people suffering from diseases once seen as incurable.

Microbix Biosystems Inc. is a Canada-based company. The Company is engaged in the development, manufacturing and distribution of cell-based products and technology and, provision of facility, technical and production personnel for contract research and development. Sequent Biotechnologies... more

Ciphergen is dedicated to the discovery of protein biomarkers and panels of biomarkers and their development into protein molecular diagnostic tests that improve patient care; and to providing collaborative R&D services through its Biomarker Discovery Center(R) laboratories for biomarker... more

MDS Proteomics is a drug discovery and development company transforming the detection and treatment of disease through proteomics. MDS Proteomics is working with Cephalon to apply proteomics to drug discovery and development across the value chain. MDS Proteomics and... more

Visible Genetics Inc. (VGI) is a leading international manufacturer of unique, high performance, automated DNA sequencing systems and tests for the analysis of genes linked to disease including HIV, hepatitis B, hepatitis C, other infectious diseases and cancer. Founded in 1993, VGI is a... more

AVI BioPharma, Inc. (AVI) is a biopharmaceutical company developing therapeutic products principally based on third-generation NeuGene antisense technology. The Company’s principal products in development target life-threatening diseases, including cardiovascular, infectious, and genetic... more

Mirus Bio Corporation is a biopharmaceutical company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products. Under development are RNAi gene silencing therapies based on Mirus' proprietary Dynamic PolyConjugatesÔ delivery platform... more

Molecular Insight Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of molecular imaging pharmaceuticals and targeted radiotherapeutics designed to improve patient diagnosis, treatment and management. During the year ended... more

NovaScreen Biosciences Corporation, a Caliper Life Sciences company, is a leading provider of drug discovery and development services and products, with a focus on in vitro (laboratory-based) screening assays and in silico (computer-based) predictive screening tools. Services and products... more

Founded in 1975, Molecular Probes is the leading worldwide provider of fluorescence-based detection solutions to advance scientific and biomedical research. Molecular Probes' research-driven strategy has produced an extensive product line that includes a wide range of fluorescent probes... more

BioMimetic Pharmaceuticals, Inc. is a late-stage bio-therapeutics company focused on the development and commercialization of innovative protein-based products for the treatment of musculoskeletal and orthopedic disorders including bone, cartilage, tendon and ligament injuries - the most... more

Epimmune Inc. is a leader in using gene maps of cancer-associated proteins and infectious agents to design vaccines that induce cellular immunity. The company's technology platform is based on its pioneering work in deciphering the genetic code which regulates T-cell activation and... more

LifeSpan is the industry leader in molecular pathology. LifeSpan sells antibodies, immunohistochemistry services and localization databases. Founded in 1995, LifeSpan has developed proprietary antibodies to major classes of drug targets to study the expression of these proteins in normal... more

Reata Pharmaceuticals, Inc. is a biopharmaceutical company focused on selecting innovative technologies and translating them into marketed drugs that address major unmet needs in intractable diseases such as cancer, inflammation and neurodegenerative disease. The company's two lead... more

About Morphochem AG (www.morphochem.de): Morphochem was founded in 1998 and currently employs 45 staff in Munich, Germany and Basel, Switzerland. It has developed a unique and highly integrated chemical genomics drug discovery platform that it is applying to the development of a pipeline... more

Iconix is improving drug safety and efficacy through application of genomics technology to predict therapeutic success. We enable pharmaceutical and biotech customers to progress the right compounds more efficiently through drug discovery and development and apply critical tools that aid... more

Genomatica is a privately owned, venture capital funded company. In addition to the financial and technological contributions provided by its founders, it has enjoyed two successful rounds of venture financing. The Company's initial private financing closed 2001 with an equity investment... more

Viagene Biotech is incorporated in the state of Florida. Our company is involved in the development and production of life-science equipment and reagents. Each of us at Viagene Biotech is committed to our company's vision to play a vital role in research that leads to better lives through... more

Aton Pharma, Inc. is a privately held biopharmaceuticals company that was founded in 2001 by a group of leading cancer investigators to develop and commercialize novel therapeutics for cancer and other diseases that were discovered in the respective laboratories of co-founders Ronald... more

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME's principal focus has been on applying its proprietary AMEsystemÔ technology platform to... more

Codon Devices is a privately-held biotechnology company focused on enabling commercial applications of synthetic biology. Codon Devices' proprietary synthesis and design technologies improve the productivity, throughput and flexibility of its industrial, pharmaceutical and academic... more

Protana Inc., successor to the business of MDS Proteomics Inc., offers an integrated suite of leading-edge technologies - protein identification, protein interaction mapping, differential analysis, phosphoprofiling, chemical proteomics, bioinformatics, small molecule hit discovery and... more

Synthetic Genomics, Inc., a privately held company founded in 2005, is dedicated to developing and commercializing genomic-driven solutions to address global energy and environmental challenges. The scientific strength at Synthetic Genomics lies in the decades of pioneering scientific... more

Genzyme Biosurgery is a leading developer of novel biotherapeutic and biomaterial products used to treat serious diseases. Its products and pipeline are concentrated in the rapidly growing markets of orthopaedics and heart disease and in broader surgical applications.

Lpath, Inc., headquartered in San Diego, California, is the category leader in lipidomics-based therapeutics, an emerging field of medical science whereby bioactive signaling lipids are targeted for treating important human diseases. Lpath's lead product candidate, ASONEPÔ (the systemic... more

Graffinity Technologies is the premier source for discovery of small molecular hit and lead compounds. Through our fragment based drug discovery platform we serve our partners in providing novel small molecules for drug discovery and chemical genomics approaches.

OGS is the world's leading proteomics based drug discovery and development company headquartered in Oxfordshire, UK, applying its proteomics technology to pharmaceutical research and development. OGS has proteomics collaborations with a number of major pharmaceutical companies, including... more

SelectX is committed to attracting and employing only the most capable scientific and professional staff available, fully understanding that the human resource is our most valuable and powerful resource. We are constantly looking for energetic, ambitious scientific and professional... more

Source MDx is focused on the development of RNA-based biomarkers and companion diagnostics in inflammation related therapeutic areas including oncology, cardiovascular, autoimmune and infectious diseases for pharmaceutical and biotech companies. Founded in 1998, Source MDx has pioneered... more

JADO's mission is to develop a generation of novel pharmaceutical products for a wide range of human diseases using a revolutionary drug development platform called RAFT Intervention Technology®. This discovery platform exploits a paradigm shift in the understanding of cell membrane... more

Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies, Group Inc. is a pioneer in the research and development and marketing of medical nutritional supplements. Millennium owns the exclusive rights to RESURGEX® and RESURGEX Plusä, multiple action... more

DNA Phenomics is a genomics research and development company focused on the discovery of diagnostic healthcare products. Working hand-in-hand with its research partners and scientific affiliates, the company is focused on developing products that allow physicians and patients to make... more

Prediction Sciences is a pioneer in the emerging field of predictive medicine. We know that the success of our company depends on the talents, efforts and achievements of our employees. Therefore, we are committed to providing a work environment that promotes teamwork, fosters creativity... more

Founded in 2000, Beyond Genomics is an emerging biotechnology company that applies its proprietary Systems Biology platforms to develop novel therapeutics and biomarkers. Current approaches such as genomics and proteomics focus on one aspect of biological systems at a time. Rather than... more

PHASE-1 Molecular Toxicology Inc. (http://www.phase1tox.com/) was founded in 1995 as a toxicogenomics company -- the first commercial toxicogenomics corporation in world history. Currently, PHASE-1 remains the only company totally dedicated to toxicogenomics. PHASE-1's core competencies... more

Biodesix is a pioneer in enabling personalized medicine by focusing on the unique characteristics of the patient using mass spectrometry based molecular diagnostics. By rapidly and cost-effectively analyzing the concurrent presence of many proteins in patient samples, Biodesix's products... more

Maple Biosciences is developing new diagnostic instruments based on biosensor technology that will be able to perform highly complex lab tests in a matter of minutes. To achieve our development goals, MedMira has acquired SensorChem International, a company that was founded based on... more